Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 21, 2020; 26(35): 5362-5374
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5362
Published online Sep 21, 2020. doi: 10.3748/wjg.v26.i35.5362
Table 1 Study characteristics
Ref. | Publication year | Country of study | Type of study | DXA scan1 | No. of patients | Average age of patients | Cohort | Control group | Follow- up | Comments |
Andreassen et al[1] | 1998 | Denmark | Cross-sectional study inviting all IBD patients from a well-defined area | Yes | 115 | 37 (16-75); median (range) | CD only | No | No | |
Andreassen et al[2] | 1999 | Denmark | Cross-sectional case-control study inviting all IBD patients from a well-defined area | Yes | 113 | 37 (16-75); median (range) | CD only | Yes; n = 113 | No | Same cohort used as in Andreassen et al[14] (1998) |
Bernstein et al[3] | 20032 | United States | Cross-sectional data extracted from population-based Manitoba IBD research registry | Yes | 70; UC: n = 12; CD: n = 58 | 33.0 (7.4); mean (SD) | UC and CD | No | No | Includes only premenopausal women |
Bernstein et al[4] | 20033 | United States | Cross-sectional data extracted from population-based Manitoba IBD research registry | Yes | 66 (DXA results: n = 70); UC: n = 11; CD: n = 55 | 33.3 (18-44); mean (range) | UC and CD | No | No | Includes only premenopausal women. Same cohort used as in Bernstein (2002) |
Haugeberg et al[5] | 2001 | Norway | Cross-sectional data from a population-based study. Case control study | Yes | 55 | 38.5 (12.7); mean (SD) | CD only | Yes; n = 52 | No | |
Jahnsen et al[6] | 1997 | Norway | Cross-sectional case control study | Yes | 60 | 36 (21-75); median (range) | CD only | Yes; n = 60 | No | Includes a cohort of UC patients that is not population-based which was therefore not included |
Jahnsen et al[7] | 2004 | Norway | Follow-up study | Yes | 60 | 36 (21-75); median (range) | CD only | No | Yes | Includes a cohort of UC patients that is not population-based which was therefore not included |
2 yr | Same cohort used as in Jahnsen (1997) | |||||||||
Leslie et al[8] | 2008 | Canada | Follow-up study with cohort extracted from population-based Manitoba IBD research registry | Yes | 101; UC: n = 45; CD: n = 56 | 46.9 (15.5); mean (SD) | UC and CD | No | Yes; 2.3 ± 0.3 yr | |
Leslie et al[9] | 2009 | Canada | Follow-up study with cohort extracted from population-based Manitoba IBD research registry | Yes | 101 UC: n = 45 CD: n = 56 | 47 (15); mean (SD) | UC and CD | No | Yes; 2.3 ± 0.3 yr | Same cohort used as in Leslie et al[19] (2008) |
Schoon et al[10] | 2000 | The Netherlands | Cross-sectional cohort | Yes | 119 | 42 (14); mean (SD) | CD only | No | No | |
Targownik et al[11] | 2012 | Canada | Follow-up study with data extracted from population-based Manitoba IBD research registry | Yes | 86; UC: n = 32; CD: n = 50; Unclass: n = 4 | 46.7 (14.9); mean (SD); 46 (35-57) median (IQR) | UC and CD | No | Yes; 4.3 ± 0.3 yr | Same cohort used as in Leslie et al[19] (2008) |
Tsai et al[12] | 2015 | Taiwan | Follow-up case control study with data extracted from population-based registry | No | 3141; UC: n = 1489; CD: n = 1652 | 46.7 (35.6-61.0); median (IQR) | UC and CD | Yes; n = 12564 | Yes; 6.49 ± 3.09 yr | Diagnosis of osteoporosis based on ICD-10 codes |
Table 2 Quality assessment according to the Newcastle–Ottawa Scale
Schoon et al[13] (2000) | Jahnsen et al[12] (1997) | Jahnsen et al[16] (2004) | Tsai et al[18] (2015) | Targownik et al[3] (2012) | Leslie et al[20] (2009) | Leslie et al[19] (2008) | Andreassen et al[14] (1998) | Andreassen et al[15] (1999) | Bernstein et al[21] (2003, May) | Bernstein et al[22] (2003, November) | Haugeberg et al[17] (2001) | |
Selection | ** | *** | ** | **** | ** | ** | ** | ** | *** | ** | ** | *** |
Comparability | ** | ** | ** | ** | ||||||||
Outcome | * | * | ** | ** | *** | ** | ** | * | * | * | * | * |
Total number of stars allocated | 3 | 6 | 4 | 7 | 5 | 4 | 4 | 3 | 6 | 3 | 3 | 6 |
Table 3 Overview of most relevant risk factors for low bone mineral density or osteoporosis
Risk factors for reduced BMD | CD | CD + UC | Comments |
General risk factors | |||
Gender[5,6,9,10] | +/- | + | Female gender was found to be significantly correlated by Leslie et al[20] (2009) investigating both CD and UC patients. In CD studies, Haugeberg et al[5] found female gender to be a predictive factor for osteoporosis. Jahnsen et al[6] found men to have lower Z-scores than women, whereas Schoon et al[10] found no significant association. |
Age[2,3,5,9] | + | +/- | Age was significantly associated in the CD studies. However, Haugeberg et al[5] found patients with reduced BMD to be significantly younger than those without reduced BMD. |
Weight[2,3,5,9] | +, -1 | + | Low weight was found to be a risk factor for low BMD in both CD + UC cohorts. In CD cohorts, Andreassen et al[15] (1999) found a significant positive correlation only in males. Haugeberg et al[17] found a positive correlation between weight and BMD for both genders. |
BMI[2,5,6,9] | +/- | + | Leslie et al[20] (2009), the only study investigating BMI in CD + UC, found a positive correlation between BMI and BMD. Haugeberg et al[17] found a significant association for CD patients in a bivariate analysis, but not in a multiple linear regression analysis. |
Steroid treatment[2,3,5,6,9] | +/-2 | - | Multiple risk factors related to steroid usage were investigated. No correlation was found in CD + UC. However, most CD studies did find a correlation. |
Height[3,5,9] | +/- | +/- | |
Smoking[3,5,6] | - | - | |
Vitamin D supplement[3-5] | - | - | |
Calcium supplement[3-5] | - | - | |
Serum 25(OH)D[1,5,8] | +/- | +/- | |
Serum calcium[1,5,8] | - | - | |
Serum parathyroid hormone[1,5,8] | +/- | + | |
Disease-specific risk factors | |||
UC diagnosis[3,9] | Not relevant | - | |
CD diagnosis[3,6,9] | Not relevant | +/- | |
Disease location[1,3,5] | - | - | |
Disease duration[2,3,5,6] | +3,- | - | |
Surgery[2,3,5,6] | +/- | - |
Table 4 Overview of the most relevant risk factors for change in bone mineral density over time
Risk factors for change in BMD | CD | CD + UC | Comments |
General risk factors | |||
Gender[8,9,11,12] | No data | +/- | No difference was found between genders in one study cohort[8,9,12], whilst another cohort[11] found a greater incidence of osteoporosis in women than in men. |
Age[8,9,11,12] | No data | +/- | |
Weight[9,11] | No data | + | |
BMI[7,9,11] | + | + | |
Steroid treatment[7-9,11] | - | +/- | |
Smoking[7] | - | No data | |
Serum 25-OH D[7,8,11] | + | +/- | |
Disease-specific risk factors | |||
Diagnosis[9,11,12] | Not relevant | +1, - | One[13] out of three studies found CD to be associated with an increased risk of osteoporosis. The others found no associations. |
Disease location[7] | - | No data | |
Disease activity[11] | No data | - |
- Citation: Kärnsund S, Lo B, Bendtsen F, Holm J, Burisch J. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease. World J Gastroenterol 2020; 26(35): 5362-5374
- URL: https://www.wjgnet.com/1007-9327/full/v26/i35/5362.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i35.5362